Market revenue in 2024 | USD 166.6 million |
Market revenue in 2030 | USD 199.6 million |
Growth rate | 3.1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.02% in 2024. Horizon Databook has segmented the India hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
India's HAI diagnostics market sees strong participation from global players such as BD and Meridian Bioscience, along with domestic firms such as Transasia Bio-Medicals, Mykab discovery solutions. For instance, in February 2023, Mylab Discovery Solutions and Thermo Fisher Scientific collaborated to provide RT-PCR kits for infectious illnesses in India.
The demand for urinalysis and blood tests is rising due to the high incidence of UTIs and bloodstream infections in Indian hospitals. Cost-sensitive market dynamics drive the preference for conventional diagnostics, though molecular diagnostics are gaining traction in urban healthcare facilities. Partnerships between global leaders and Indian companies help expand product reach while ensuring affordability.
Horizon Databook provides a detailed overview of country-level data and insights on the India hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into India hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account